Benzinga's Top Downgrades
- Citigroup downgraded Goldman Sachs Group Inc (NYSE: GS) from Buy to Neutral. Goldman Sachs shares fell 0.56 percent to $180.47 in pre-market trading.
- Analysts at Deutsche Bank downgraded Bank of America Corp (NYSE: BAC) from Buy to Hold. Bank of America shares dropped 0.71 percent to $16.89 in pre-market trading.
- Morgan Stanley downgraded Cempra Inc (NASDAQ: CEMP) from Overweight to Underweight. The price target for Cempra has been lowered from $35 to $5. Cempra shares fell 9.56 percent to $6.20 in pre-market trading.
- Barclays downgraded Bristow Group Inc (NYSE: BRS) from Overweight to Equal-Weight. The price target for Bristow Group has been lowered from $20 to $16. Bristow Group shares rose 3.78 percent to close at $12.07 on Monday.
- Analysts at Deutsche Bank downgraded Hertz Global Holdings, Inc (NYSE: HTZ) from Buy to Hold. Hertz Global shares fell 38.02 percent to $22.15 in pre-market trading.
- Credit Suisse downgraded Fluor Corporation (NEW) (NYSE: FLR) from Outperform to Neutral. The price target for Fluor has been lowered from $53 to $49. Fluor shares fell 0.85 percent to $44.48 in pre-market trading.
- Analysts at Stifel Nicolaus downgraded Kindred Healthcare, Inc. (NYSE: KND) from Hold to Sell. Kindred Healthcare shares dropped 26.86 percent to $6.40 in pre-market trading.
- Evercore ISI Group downgraded Best Buy Co Inc (NYSE: BBY) from Hold to Sell. Best Buy shares fell 3.79 percent to $37.59 in pre-market trading.
- Bank of America downgraded OneMain Holdings Inc (NYSE: OMF) from Buy to Underperform. The price target for OneMain Holdings has been lowered from $35 to $21. OneMain Holdings shares declined 31.81 percent to $18.80 in pre-market trading.
- Analysts at Oppenheimer downgraded AT&T Inc. (NYSE: T) from Outperform to Perform. AT&T shares fell 0.43 percent to $36.65 in pre-market trading.
Latest Ratings for CEMP
Date | Firm | Action | From | To |
---|---|---|---|---|
Nov 2017 | Baird | Upgrades | Underperform | Neutral |
Aug 2017 | Roth Capital | Downgrades | Buy | Neutral |
Mar 2017 | Gabelli & Co. | Downgrades | Sell |
View More Analyst Ratings for CEMP
View the Latest Analyst Ratings
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Top DowngradesDowngrades Analyst Ratings